Atlas Trials

Combined Treatment of RFA and Sorafenib on Recurrent HCC

Clinical trial NCT01470495 · UNKNOWN

Trial details

NCT number
NCT01470495
Sponsor
Southwest Hospital, China
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
HCCRadiofrequency AblationSorafenib
Start date
2015-01-01
Primary completion
2018-12-01
Enrollment
430

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.